{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T16:08:34Z","timestamp":1787587714245,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","issue":"13-14","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Biochemistry"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.clinbiochem.2015.04.007","type":"journal-article","created":{"date-parts":[[2015,4,17]],"date-time":"2015-04-17T22:21:52Z","timestamp":1429309312000},"page":"849-854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["KLKB1 mRNA overexpression: A novel molecular biomarker for the diagnosis of chronic lymphocytic leukemia"],"prefix":"10.1016","volume":"48","author":[{"given":"Panagiotis G.","family":"Adamopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9935-8461","authenticated-orcid":false,"given":"Christos K.","family":"Kontos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3376-837X","authenticated-orcid":false,"given":"Sotirios G.","family":"Papageorgiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Pappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Scorilas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1634\/theoncologist.11-1-21","article-title":"Chronic lymphocytic leukemia: recent advances in diagnosis and treatment","volume":"11","author":"Abbott","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0010","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1046\/j.1468-0734.2000.00001.x","article-title":"Biology of chronic lymphocytic leukemia","volume":"4","author":"Caligaris-Cappio","year":"2000","journal-title":"Rev. Clin. Exp. Hematol."},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0015","series-title":"Leukaemia and associated diseases","author":"Hamblin","year":"1998"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0020","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1056\/NEJM199510193331606","article-title":"Chronic lymphocytic leukemia","volume":"333","author":"Rozman","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0025","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"Hallek","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0030","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1097-0142(19810701)48:1<198::AID-CNCR2820480131>3.0.CO;2-V","article-title":"A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis","volume":"48","author":"Binet","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1182\/blood.V46.2.219.219","article-title":"Clinical staging of chronic lymphocytic leukemia","volume":"46","author":"Rai","year":"1975","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0040","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1074\/mcp.M300055-MCP200","article-title":"Proteomic analysis of chronic lymphocytic leukemia subtypes with mutated or unmutated Ig V(H) genes","volume":"2","author":"Cochran","year":"2003","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0045","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"Hamblin","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0050","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"Damle","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00439-007-0340-4","article-title":"Common variation in KLKB1 and essential hypertension risk: tagging-SNP haplotype analysis in a case\u2013control study","volume":"121","author":"Lu","year":"2007","journal-title":"Hum. Genet."},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0060","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1515\/BC.2007.104","article-title":"Cellular expression of plasma prekallikrein in human tissues","volume":"388","author":"Fink","year":"2007","journal-title":"Biol. Chem."},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0065","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0143-4004(96)90042-9","article-title":"High and low molecular weight kininogen and plasma prekallikrein\/plasma kallikrein in villous capillaries of human term placenta","volume":"17","author":"Hermann","year":"1996","journal-title":"Placenta"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0070","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0162-3109(99)00112-5","article-title":"Plasma kallikrein localisation in human blood vessels","volume":"44","author":"Cerf","year":"1999","journal-title":"Immunopharmacology"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0075","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1023\/A:1011179426420","article-title":"Immunolocalization of plasma kallikrein in human brain","volume":"15","author":"Cerf","year":"2000","journal-title":"Metab. Brain Dis."},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0080","doi-asserted-by":"crossref","first-page":"4990","DOI":"10.1182\/blood.V87.12.4990.bloodjournal87124990","article-title":"National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment","volume":"87","author":"Cheson","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0085","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1182\/blood.V99.3.1023","article-title":"CD38 expression and immunoglobulin variable region mutations are independent prognostic variables in chronic lymphocytic leukemia, but CD38 expression may vary during the course of the disease","volume":"99","author":"Hamblin","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0090","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1182\/blood.V84.5.1415.bloodjournal8451415","article-title":"Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis","volume":"84","author":"Koopman","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0095","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1182\/blood-2006-03-012948","article-title":"Over 20% of patients with chronic lymphocytic leukemia carry stereotyped receptors: pathogenetic implications and clinical correlations","volume":"109","author":"Stamatopoulos","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0100","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1182\/blood-2004-07-2606","article-title":"Geographic patterns and pathogenetic implications of IGHV gene usage in chronic lymphocytic leukemia: the lesson of the IGHV3-21 gene","volume":"105","author":"Ghia","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0105","doi-asserted-by":"crossref","first-page":"D593","DOI":"10.1093\/nar\/gki065","article-title":"IMGT, the international ImMunoGeneTics information system","volume":"33","author":"Lefranc","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0110","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(\u2212delta delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0115","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0120","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1182\/asheducation.V2012.1.76.3806845","article-title":"Implications of new prognostic markers in chronic lymphocytic leukemia","volume":"2012","author":"Chiorazzi","year":"2012","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0125","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1046\/j.1365-2141.2001.03149.x","article-title":"Analysis of clonal B-cell CD38 and immunoglobulin variable region sequence status in relation to clinical outcome for B-chronic lymphocytic leukaemia","volume":"115","author":"Jelinek","year":"2001","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0130","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s001090050350","article-title":"Chromosome aberrations in B-cell chronic lymphocytic leukemia: reassessment based on molecular cytogenetic analysis","volume":"77","author":"Dohner","year":"1999","journal-title":"J. Mol. Med. (Berl.)"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0135","doi-asserted-by":"crossref","first-page":"138","DOI":"10.4161\/epi.23439","article-title":"Uncovering the DNA methylome in chronic lymphocytic leukemia","volume":"8","author":"Cahill","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0140","doi-asserted-by":"crossref","first-page":"e68074","DOI":"10.1371\/journal.pone.0068074","article-title":"Evolution of the plasma and tissue kallikreins, and their alternative splicing isoforms","volume":"8","author":"Koumandou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0145","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1158\/1541-7786.257.2.5","article-title":"Human tissue kallikreins: physiologic roles and applications in cancer","volume":"2","author":"Borgono","year":"2004","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0150","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1515\/cclm-2012-0247","article-title":"Kallikrein-related peptidases (KLKs): a gene family of novel cancer biomarkers","volume":"50","author":"Kontos","year":"2012","journal-title":"Clin. Chem. Lab. Med."},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0155","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1373\/clinchem.2008.105189","article-title":"Utility of kallikrein-related peptidases (KLKs) as cancer biomarkers","volume":"54","author":"Emami","year":"2008","journal-title":"Clin. Chem."},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0160","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1515\/bc.2010.056","article-title":"Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies","volume":"391","author":"Avgeris","year":"2010","journal-title":"Biol. Chem."},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0165","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1515\/hsz-2011-0260","article-title":"Kallikrein-related peptidases in prostate, breast, and ovarian cancers: from pathobiology to clinical relevance","volume":"393","author":"Avgeris","year":"2012","journal-title":"Biol. Chem."},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0170","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S1567-5769(01)00193-X","article-title":"Roles of bradykinin in vascular permeability and angiogenesis in solid tumor","volume":"2","author":"Ishihara","year":"2002","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0175","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/j.1349-7006.2001.tb01114.x","article-title":"Enhanced vascular permeability in solid tumor involving peroxynitrite and matrix metalloproteinases","volume":"92","author":"Wu","year":"2001","journal-title":"Jpn. J. Cancer Res."},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0180","first-page":"159","article-title":"Modulation of enhanced vascular permeability in tumors by a bradykinin antagonist, a cyclooxygenase inhibitor, and a nitric oxide scavenger","volume":"58","author":"Wu","year":"1998","journal-title":"Cancer Res."},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0185","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ab.2005.12.002","article-title":"Lab assembly of a low-cost, robust SYBR green buffer system for quantitative real-time polymerase chain reaction","volume":"350","author":"Pellissier","year":"2006","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0190","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jprot.2013.08.002","article-title":"Proteomic analysis of B-cell receptor signaling in chronic lymphocytic leukaemia reveals a possible role for kininogen","volume":"91","author":"Kashuba","year":"2013","journal-title":"J. Proteomics"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0195","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1182\/blood.V98.9.2633","article-title":"Clinical significance of CD38 expression in chronic lymphocytic leukemia","volume":"98","author":"Del Poeta","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0200","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.leu.2402339","article-title":"CD38 expression is an important prognostic marker in chronic lymphocytic leukaemia","volume":"16","author":"Durig","year":"2002","journal-title":"Leukemia"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0205","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1182\/blood.V98.1.181","article-title":"CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia","volume":"98","author":"Ibrahim","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0210","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/S0145-2126(01)00049-2","article-title":"Peripheral blood CD38 expression predicts survival in B-cell chronic lymphocytic leukemia","volume":"25","author":"Morabito","year":"2001","journal-title":"Leuk. Res."},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0215","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/10245330400020470","article-title":"CD38 as a prognostic marker in CLL","volume":"10","author":"Matrai","year":"2005","journal-title":"Hematology"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0220","first-page":"1732","article-title":"Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia","volume":"93","author":"Hallek","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0225","doi-asserted-by":"crossref","first-page":"4973","DOI":"10.1182\/blood-2006-11-054916","article-title":"CLLU1 expression analysis adds prognostic information to risk prediction in chronic lymphocytic leukemia","volume":"109","author":"Josefsson","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0230","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/1097-0142(20010815)92:4<713::AID-CNCR1374>3.0.CO;2-O","article-title":"Elevated serum levels of soluble CD44 can identify a subgroup of patients with early B-cell chronic lymphocytic leukemia who are at high risk of disease progression","volume":"92","author":"Molica","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.clinbiochem.2015.04.007_bb0235","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1043-2760(99)00225-8","article-title":"The new human kallikrein gene family: implications in carcinogenesis","volume":"11","author":"Diamandis","year":"2000","journal-title":"Trends Endocrinol. Metab."}],"container-title":["Clinical Biochemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015001319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009912015001319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T15:46:03Z","timestamp":1757864763000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009912015001319"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":47,"journal-issue":{"issue":"13-14","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S0009912015001319"],"URL":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.04.007","relation":{},"ISSN":["0009-9120"],"issn-type":[{"value":"0009-9120","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"KLKB1 mRNA overexpression: A novel molecular biomarker for the diagnosis of chronic lymphocytic leukemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Biochemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinbiochem.2015.04.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}